Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4 -dose Regimen of V114 in Healthy Infants (PNEU-PED)
Rupp, Richard
(PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/25/19
→
4/24/23
Funding
Merck Sharp and Cohme Corporation ( Award # ):
$6,000.00
View all
View less